| UniProt ID | CD4_HUMAN | |
|---|---|---|
| UniProt AC | P01730 | |
| Protein Name | T-cell surface glycoprotein CD4 | |
| Gene Name | CD4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 458 | |
| Subcellular Localization |
Cell membrane Single-pass type I membrane protein . Localizes to lipid rafts (PubMed:12517957, PubMed:9168119). Removed from plasma membrane by HIV-1 Nef protein that increases clathrin-dependent endocytosis of this antigen to target it to lysosoma |
|
| Protein Description | Integral membrane glycoprotein that plays an essential role in the immune response and serves multiple functions in responses against both external and internal offenses. In T-cells, functions primarily as a coreceptor for MHC class II molecule:peptide complex. The antigens presented by class II peptides are derived from extracellular proteins while class I peptides are derived from cytosolic proteins. Interacts simultaneously with the T-cell receptor (TCR) and the MHC class II presented by antigen presenting cells (APCs). In turn, recruits the Src kinase LCK to the vicinity of the TCR-CD3 complex. LCK then initiates different intracellular signaling pathways by phosphorylating various substrates ultimately leading to lymphokine production, motility, adhesion and activation of T-helper cells. In other cells such as macrophages or NK cells, plays a role in differentiation/activation, cytokine expression and cell migration in a TCR/LCK-independent pathway. Participates in the development of T-helper cells in the thymus and triggers the differentiation of monocytes into functional mature macrophages.; (Microbial infection) Primary receptor for human immunodeficiency virus-1 (HIV-1). [PubMed: 2214026] | |
| Protein Sequence | MNRGVPFRHLLLVLQLALLPAATQGKKVVLGKKGDTVELTCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRSLWDQGNFPLIIKNLKIEDSDTYICEVEDQKEEVQLLVFGLTANSDTHLLQGQSLTLTLESPPGSSPSVQCRSPRGKNIQGGKTLSVSQLELQDSGTWTCTVLQNQKKVEFKIDIVVLAFQKASSIVYKKEGEQVEFSFPLAFTVEKLTGSGELWWQAERASSSKSWITFDLKNKEVSVKRVTQDPKLQMGKKLPLHLTLPQALPQYAGSGNLTLALEAKTGKLHQEVNLVVMRATQLQKNLTCEVWGPTSPKLMLSLKLENKEAKVSKREKAVWVLNPEAGMWQCLLSDSGQVLLESNIKVLPTWSTPVQPMALIVLGGVAGLLLFIGLGIFFCVRCRHRRRQAERMSQIKRLLSEKKTCQCPHRFQKTCSPI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 67 | Phosphorylation | KILGNQGSFLTKGPS EEECCCCCCCCCCCC | 13.81 | 23401153 | |
| 70 | Phosphorylation | GNQGSFLTKGPSKLN CCCCCCCCCCCCCCC | 31.76 | 26074081 | |
| 74 | Phosphorylation | SFLTKGPSKLNDRAD CCCCCCCCCCCCCHH | 59.45 | 22617229 | |
| 296 | N-linked_Glycosylation | PQYAGSGNLTLALEA CCCCCCCCEEEEEEE | 31.39 | UniProtKB CARBOHYD | |
| 325 | N-linked_Glycosylation | RATQLQKNLTCEVWG EHHHHHHCCEEEEEC | 27.85 | 2592374 | |
| 419 | S-palmitoylation | IGLGIFFCVRCRHRR HHHHHHHHHHHHHHH | 1.00 | 12517957 | |
| 422 | S-palmitoylation | GIFFCVRCRHRRRQA HHHHHHHHHHHHHHH | 1.83 | 12517957 | |
| 433 | Phosphorylation | RRQAERMSQIKRLLS HHHHHHHHHHHHHHH | 34.67 | 22817900 | |
| 436 | Ubiquitination | AERMSQIKRLLSEKK HHHHHHHHHHHHHCC | 29.38 | - | |
| 440 | Phosphorylation | SQIKRLLSEKKTCQC HHHHHHHHHCCCCCC | 52.54 | 22817900 | |
| 453 | Ubiquitination | QCPHRFQKTCSPI-- CCCCCCCCCCCCC-- | 49.11 | - | |
| 456 | Phosphorylation | HRFQKTCSPI----- CCCCCCCCCC----- | 30.75 | 9168119 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 433 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
| 440 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
| - | K | Ubiquitination | E3 ubiquitin ligase | MARCHF4 | Q9P2E8 | PMID:14722266 |
| - | K | Ubiquitination | E3 ubiquitin ligase | MARCHF1 | Q8TCQ1 | PMID:22199232 |
| - | K | Ubiquitination | E3 ubiquitin ligase | MARCHF9 | Q86YJ5 | PMID:17174307 |
| - | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:11893391 |
| - | K | Ubiquitination | E3 ubiquitin ligase | MARCHF11 | A6NNE9 | PMID:17604280 |
| - | K | Ubiquitination | E3 ubiquitin ligase | 5L | Q9DHV7 | PMID:22199232 |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 433 | S | Phosphorylation |
| 2105883 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CD4_HUMAN !! | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-296, AND MASSSPECTROMETRY. | |
| Palmitoylation | |
| Reference | PubMed |
| "Identification of palmitoylation sites on CD4, the humanimmunodeficiency virus receptor."; Crise B., Rose J.K.; J. Biol. Chem. 267:13593-13597(1992). Cited for: PALMITOYLATION AT CYS-419 AND CYS-422. | |